R

Ryvu Therapeutics SA
WSE:RVU

Watchlist Manager
Ryvu Therapeutics SA
WSE:RVU
Watchlist
Price: 27.8 PLN 0.54%
Market Cap: 642.7m PLN

Intrinsic Value

The intrinsic value of one RVU stock under the Base Case scenario is hidden PLN. Compared to the current market price of 27.8 PLN, Ryvu Therapeutics SA is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

RVU Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Ryvu Therapeutics SA

Intrinsic Value History
Dive into the past to invest in the future

RVU looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if RVU is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about RVU?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is RVU valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Ryvu Therapeutics SA.

Explain Valuation
Compare RVU to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about RVU?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Ryvu Therapeutics SA

Current Assets 162.6m
Cash & Short-Term Investments 136.6m
Receivables 18.2m
Other Current Assets 7.9m
Non-Current Assets 92.7m
Long-Term Investments 17.4m
PP&E 68.3m
Intangibles 7m
Other Non-Current Assets 1k
Current Liabilities 71.7m
Accounts Payable 21.5m
Accrued Liabilities 7.8m
Other Current Liabilities 42.3m
Non-Current Liabilities 112.4m
Long-Term Debt 78.1m
Other Non-Current Liabilities 34.3m
Efficiency

Free Cash Flow Analysis
Ryvu Therapeutics SA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Ryvu Therapeutics SA

Revenue
69.8m PLN
Cost of Revenue
-20.3m PLN
Gross Profit
49.5m PLN
Operating Expenses
-171.2m PLN
Operating Income
-121.8m PLN
Other Expenses
3.1m PLN
Net Income
-118.7m PLN
Fundamental Scores

RVU Profitability Score
Profitability Due Diligence

Ryvu Therapeutics SA's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Gross Margin is Increasing
Net Margin is Increasing
hidden
Profitability
Score

Ryvu Therapeutics SA's profitability score is hidden . The higher the profitability score, the more profitable the company is.

RVU Solvency Score
Solvency Due Diligence

Ryvu Therapeutics SA's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Interest Coverage
Short-Term Solvency
Negative Net Debt
Long-Term Solvency
hidden
Solvency
Score

Ryvu Therapeutics SA's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RVU Price Targets Summary
Ryvu Therapeutics SA

Wall Street analysts forecast RVU stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RVU is 54.5 PLN with a low forecast of 29.29 PLN and a high forecast of 104.27 PLN.

Lowest
Price Target
29.29 PLN
5% Upside
Average
Price Target
54.5 PLN
96% Upside
Highest
Price Target
104.27 PLN
275% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Ryvu Therapeutics SA
does not pay dividends
Shareholder Yield

Current shareholder yield for RVU is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one RVU stock?

The intrinsic value of one RVU stock under the Base Case scenario is hidden PLN.

Is RVU stock undervalued or overvalued?

Compared to the current market price of 27.8 PLN, Ryvu Therapeutics SA is hidden .

Back to Top